An antibody used to treat the skin disease psoriasis is also effective at reducing aortic inflammation, a key marker of future risk of major cardiovascular events.
A group of NUST MISIS's young scientists, for the very first time in Russia, has presented a new therapeutic material based on nanofibers made of polycaprolactone modified with a thin-film antibacterial composition and plasma components of human blood. Biodegradable bandages made from these fibers will accelerate the growth of tissue cells twice as quickly, contributing to the normal regeneration of damaged tissues, as well as preventing the formation of scars in cases of severe burns.
Study suggests opioid prescribing isn't widespread among dermatologists, but opportunities exist in concentrated areas to reduce use.
After years of investigation, researchers at Johns Hopkins, the University of California, Davis, and the National Institute of Allergy and Infectious Diseases have discovered how the immune system might protect a person from recurrent bacterial skin infections caused by Staphylococcus aureus (staph).
A new study pinpoints a mechanism that controls how basal cell cancers respond to treatment and offers new ideas for controlling this disease when it gets tricky.
When it comes to the physical scars surgery leaves behind, a new study shows patients and doctors often don't assess their severity the same way. Researchers from the Perelman School of Medicine at the University of Pennsylvania found patients and physicians disagreed in their scar evaluations 28 percent of the time, with patients more likely to focus on the depth of the scar while physicians were more likely to emphasize coloration and texture.
Building on prior research that examined the use of an arthritis medication to treat vitiligo, a team of Yale dermatologists has successfully applied a novel combination therapy -- the medication and light -- to restore skin color in patients.
A careful review of the currently available medical data shows that there is no proven causal relationship between moderate solarium use and increased melanoma risk. This is the conclusion reached by an international group of researchers headed by Professor Dr. Jörg Reichrath, Deputy Director of the Department of Dermatology, Venereology and Allergology at Saarland University Hospital in Homburg/Saar.
In an article published online ahead of print by The Journal of Pediatrics, physicians at the Medical University of South Carolina report that complications from botox therapy for nerve disorders can be reversed with pyridostigmine, a common treatment for myasthenia gravis. The report is the first such use in pediatric patients.
A new source of the botulinum neurotoxin was discovered by Canadian and American scientists in a strain of animal gut bacteria known as Enterococcus faecium. The neurotoxic protein is known for its paradoxical ability to remove wrinkles yet cause botulism, a potentially fatal illness associated with food poisoning.